Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 16, 2021 07:30 ET | Source: Zai Lab Limited

Zai Lab Expands U.S. Operations to Join the Cambridge Biotechnology Community

SHANGHAI and SAN FRANCISCO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, announced today that it will...
September 14, 2021 07:30 ET | Source: Zai Lab Limited

Zai Lab Announces Breakthrough Therapy Designation Granted for Bemarituzumab (FPA144) in China

SHANGHAI and SAN FRANCISCO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that the Center...
September 09, 2021 07:30 ET | Source: Zai Lab Limited

Zai Lab to Host Virtual Research and Development Day on September 22, 2021

SHANGHAI and SAN FRANCISCO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced it will host a...
August 24, 2021 07:30 ET | Source: Zai Lab Limited

Zai Lab Announces Upcoming Presentations in September Investor Conferences

SHANGHAI and SAN FRANCISCO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that...
August 09, 2021 16:30 ET | Source: Zai Lab Limited

Zai Lab Announces Second Quarter 2021 Financial Results and Corporate Updates

SHANGHAI and SAN FRANCISCO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced financial results...
August 04, 2021 07:30 ET | Source: Zai Lab Limited

Schrödinger and Zai Lab Announce a Global R&D Collaboration in Oncology

NEW YORK and SHANGHAI and SAN FRANCISCO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials...
July 22, 2021 07:30 ET | Source: Zai Lab Limited

Zai Lab to Announce Second Quarter 2021 Financial Results

SHANGHAI and SAN FRANCISCO, July 22, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that it will...
June 16, 2021 07:30 ET | Source: Zai Lab Limited

Zai Lab and MacroGenics Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology

Zai Lab granted combination of regional Asian and global rights for up to four CD3- or CD47-based bispecific moleculesMacroGenics provides rights to Zai Lab for its DART® and TRIDENT® multi-specific...
June 01, 2021 07:30 ET | Source: Zai Lab Limited

Mirati Therapeutics and Zai Lab Enter Into a Collaboration to Develop and Commercialize Adagrasib in Greater China

Zai Lab obtains the right to develop and exclusively commercialize adagrasib in mainland China, Hong Kong, Macau and TaiwanMirati to receive an upfront payment of $65 million, up to approximately $273...
May 28, 2021 07:30 ET | Source: Zai Lab Limited

Zai Lab Announces First Patient Treated in China in the Registrational Phase 2 TRIDENT-1 Study of Repotrectinib

TRIDENT-1 study is enrolling patients with ROS1+ advanced NSCLC and NTRK+ advanced solid tumors. SHANGHAI and SAN FRANCISCO, May 28, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX:...